These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29785172)

  • 1. Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.
    Kuba A; Raida L
    Mediators Inflamm; 2018; 2018():9451950. PubMed ID: 29785172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
    Kuba A; Raida L; Mrazek F; Schneiderova P; Kriegova E; Langova K; Furst T; Furstova J; Faber E; Papajik T
    Ann Hematol; 2020 Mar; 99(3):609-618. PubMed ID: 32002656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence marker p16
    Kuba A; Raida L; Brychtova S; Flodr P; Mrazek F; Kriegova E; Faber E; Papajik T
    Transpl Immunol; 2023 Feb; 76():101768. PubMed ID: 36470572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute graft-vs-host disease: pathobiology and management.
    Goker H; Haznedaroglu IC; Chao NJ
    Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
    Muñiz P; Andrés-Zayas C; Carbonell D; Chicano M; Bailén R; Oarbeascoa G; Suárez-González J; Gómez Centurión I; Dorado N; Gallardo D; Anguita J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
    Front Immunol; 2022; 13():1002959. PubMed ID: 36211438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.
    Wang T; Remberger M; Axdorph Nygell U; Sundin M; Björklund A; Mattsson J; Uhlin M; Watz E
    Transfusion; 2018 Jun; 58(6):1442-1451. PubMed ID: 29536557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans.
    Yamane M; Sato S; Shimizu E; Shibata S; Hayano M; Yaguchi T; Kamijuku H; Ogawa M; Suzuki T; Mukai S; Shimmura S; Okano H; Takeuchi T; Kawakami Y; Ogawa Y; Tsubota K
    FASEB J; 2020 Aug; 34(8):10778-10800. PubMed ID: 32619061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.
    Pitea M; Canale FA; Porto G; Verduci C; Utano G; Policastro G; Alati C; Santoro L; Imbalzano L; Martino M
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
    Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease management.
    Mistrik M; Bojtarova E; Sopko L; Masakova L; Roziakova L; Martinka J; Batorova A
    Bratisl Lek Listy; 2016; 117(7):388-96. PubMed ID: 27546540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.
    Matos C; Mamilos A; Shah PN; Meedt E; Weber D; Ghimire S; Hiergeist A; Gessner A; Dickinson A; Dressel R; Walter L; Stark K; Heid IM; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Kreutz M; Ghimire S
    Front Immunol; 2022; 13():1028850. PubMed ID: 36341397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.
    Shimoni A; Nagler A
    Cancer Treat Res; 2002; 110():113-36. PubMed ID: 11908195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.